Low dose endoluminal photodynamic therapy improves murine T cell-mediated colitis
Background and study aims: Low dose photodynamic therapy (LDPDT) may modify the mucosal immune response and may thus provide a therapy for Crohn's disease. We evaluated the efficacy and safety of this technique in a murine T cell-mediated colitis model.
Keywords: Inflammatory-Bowel-Disease ; Dependent Experimental Colitis ; Adjuvant-Enhanced Arthritis ; Delta-Aminolevulinic-Acid ; Crohns-Disease ; Barretts-Esophagus ; Light Dosimetry ; Scid Mice ; Apoptosis ; Lymphocytes
Record created on 2011-06-01, modified on 2016-08-09